No Data
OrbusNeich Seeks Shareholder Approval for New Mandates
Orbusneich (06929): It is recommended to revoke the existing general mandate and grant a new general mandate.
Zhixin Finance APP News, Orbusneich (06929) announced that, due to the latest revision of the listing rules related to treasury stocks, starting from June 2024...
Does OrbusNeich Medical Group Holdings (HKG:6929) Have A Healthy Balance Sheet?
[Special Guest V] Guo Jiayao: Market anticipates more stimulating policies to be introduced in the mainland to boost consumer and real estate markets.
Jingu Finance News | US stocks performed positively on Thursday, with strong US data and China's large-scale stimulus measures, creating a bullish atmosphere in the market. All three major indices recorded gains at the close. The US dollar fluctuated downwards, with the US ten-year bond yield maintained at 3.79%, gold price hitting a new high again, and oil prices remaining soft. Hong Kong stocks generally rose, with expectations of a higher opening in the market early on. Mainland stock markets continued to perform well, with the Shanghai Composite Index opening low and rising throughout the day, closing up 3.6% at the 3,000 point level. The total trading volume of the Shanghai and Shenzhen markets once again exceeded one trillion yuan. Hong Kong stocks have been performing exceptionally well recently, with the index approaching the 20,000 point level and total market turnover increasing rapidly to
ORBUSNEICH: INTERIM REPORT 2024
Medical company Yiju Medical (06929.HK): Accelerating the flywheel, poised to unleash.
The journey of medical instrument industry to go global has always been a magnificent chapter that has inspired endless ideals and exploration desires. However, to navigate and win the trust and recognition of the international medical community, especially the overseas physician group, in the global technological wave, the difficulty is self-evident and can be described as a dual test of wisdom and strength. In the high-precision field of cardiovascular intervention therapy, Industry Chamber Medical has already emerged as a leader with extraordinary vision and strength. Based on the international market, its high-quality products have been sold to more than 70 countries and regions worldwide, and the contribution rate of overseas markets is even higher than 85%, making it a global leader in the field of cardiovascular.
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%No Data
No Data
